2024-11-06 15:11:00
(Adnkronos) - In this issue: AstraZeneca and Daiichi Sankyo present “In Seno al Futuro”, the campaign dedicated to metastatic breast cancer Incyte Forum: human and economic capital, levers to bridge the innovation gap and enhance research 45 thousand Italians l ‘year with post-stroke disorders, 57% do not know what spasticity is, the Assosalute Research survey, ‘Italians satisfied with pharmacies and family doctors’ In Milan the Jakala event dedicated to the customer experience in pharma retail Fight against smoking: doctors are the first line Breast cancer prevention: screening for over 1,400 policewomen, including very young ones The “Believing in Research” award was presented to Penny Italia by Airc Foundation The free anti-HPV vaccination campaign expands in Trento, almost 100,000 people involved in the next 3 - 4 years
#Salus #November
Interview: Bridging Innovation in Healthcare – Insights from Dr. Laura Moretti
Editor: Thank you for joining us today, Dr. Moretti. There’s some significant news about AstraZeneca and Daiichi Sankyo’s new campaign “In Seno al Futuro” dedicated to metastatic breast cancer. Can you shed some light on the importance of this initiative?
Dr. Moretti: Absolutely, and thank you for having me. The “In Seno al Futuro” campaign is pivotal as it not only raises awareness about metastatic breast cancer but also encourages open discussions regarding treatment options and innovations in care. This type of campaign is essential in demystifying the condition and improving the quality of life for patients.
Editor: That’s a great point. Furthermore, a recent survey by Assosalute revealed that 57% of Italians are unaware of what spasticity is, especially among the 45,000 Italians affected by post-stroke disorders. What steps can be taken to improve public knowledge on this topic?
Dr. Moretti: Education is key. Health campaigns that provide straightforward information about spasticity can help bridge this knowledge gap. Additionally, healthcare providers should prioritize discussions about spasticity during post-stroke rehabilitation. Community workshops and informational materials in pharmacies can also empower patients and families to understand and manage this condition better.
Editor: Speaking of healthcare providers, it was noted that Italians are generally satisfied with pharmacies and family doctors. How do you see this relationship evolving, especially with advancements in medical technology?
Dr. Moretti: The relationship between patients and their healthcare providers is crucial, especially in a rapidly evolving healthcare landscape. With the rise of telemedicine and digital health tools, pharmacies and family doctors are ideally positioned to integrate these technologies into their practice. This can enhance patient engagement and streamline the management of chronic conditions, ultimately improving health outcomes.
Editor: On a different note, the event in Milan focused on customer experience in pharmaceutical retail. What role does customer experience play in the healthcare industry?
Dr. Moretti: Customer experience is paramount in healthcare. Patients today expect not just effective treatments but also a seamless experience when interacting with healthcare providers and pharmacies. A focus on customer experience helps build trust, encourages adherence to treatment plans, and fosters loyalty to healthcare services. It can also lead to better communication and improved health literacy among patients.
Editor: The report also touched on cancer prevention initiatives, such as breast cancer screening for more than 1,400 policewomen. Why are targeted initiatives like this important?
Dr. Moretti: Targeted initiatives are critical as they address specific populations that may have unique risks and barriers to accessing screening and preventive care. By focusing on groups like policewomen, we can ensure that we reach individuals who may otherwise overlook health screenings due to demanding job responsibilities. This proactive approach can lead to early detection and better survival rates.
Editor: There’s also exciting news regarding the expansion of the anti-HPV vaccination campaign in Trento, which aims to involve nearly 100,000 individuals over the next few years. What impact do such vaccination campaigns have on public health?
Dr. Moretti: Vaccination campaigns like the one against HPV are transformative for public health. By increasing vaccination rates, we not only protect individuals from certain cancers but also reduce the overall incidence of HPV-related diseases in the community. It’s a crucial step toward achieving widespread immunity and lowering healthcare costs associated with treating these diseases in the long run.
Editor: Lastly, let’s touch on the “Believing in Research” award given to Penny Italia by the Airc Foundation. How do you see research influencing healthcare advancements?
Dr. Moretti: Research is the backbone of healthcare advancements. It drives innovation, helps us understand diseases better, and leads to the development of new treatments and preventive measures. Recognizing organizations that contribute to research fosters a culture of inquiry and collaboration that can significantly advance patient care.
Editor: Thank you, Dr. Moretti. Your insights into these pressing healthcare issues are invaluable. We appreciate your time and expertise today.
Dr. Moretti: Thank you for the opportunity to discuss these important topics. It’s essential to keep the conversation going about health awareness and innovation in our industry.